© 2013

Angiogenesis Modulations in Health and Disease

Practical Applications of Pro- and Anti-angiogenesis Targets

  • Shaker A. Mousa
  • Paul J. Davis
  • In-depth explanations of pro-angiogenesis and anti-angiogenesis targets and their evaluation methods

  • Clinical implications of pro-angiogenesis and anti-angiogenesis strategies

  • Dedicated chapter on the impact of nanotechnology, stem cells, and biotechnology in angiogenesis control

  • Detailed description of thyroid hormone analogues’ physiology and clinical potential

  • Discussion of the future in the clinic for controlling angiogenesis


Table of contents

  1. Front Matter
    Pages i-x
  2. Shaker A. Mousa, Paul J. Davis
    Pages 1-12
  3. Pro-angiogenesis Targets and Clinical Implications

    1. Front Matter
      Pages 13-13
    2. Shaker A. Mousa
      Pages 15-18
    3. Robert C. Block, Murat Yalcin, Mathangi Srinivasan, Steve Georas, Shaker A. Mousa
      Pages 19-28
    4. Paul J. Davis, Faith B. Davis, Hung-Yun Lin, Mary K. Luidens, Shaker A. Mousa
      Pages 29-46
    5. Paul J. Davis, Shaker A. Mousa, Faith B. Davis, Hung-Yun Lin
      Pages 47-53
    6. Shaker A. Mousa, Hugo R. Arias, Paul J. Davis
      Pages 55-75
    7. Dhruba J. Bharali, Shaker A. Mousa
      Pages 87-92
  4. Anti-angiogenesis Targets and Clinical Applications

    1. Front Matter
      Pages 93-93
    2. Shaker A. Mousa
      Pages 95-106
    3. Paul J. Davis, Faith B. Davis, Mary K. Luidens, Hung-Yun Lin, Shaker A. Mousa
      Pages 107-117
    4. Shaker A. Mousa, Paul J. Davis
      Pages 119-141
    5. Shaker A. Mousa, Laila H. Anwar
      Pages 143-155
    6. Shaker A. Mousa, Paul J. Davis
      Pages 199-203
  5. Back Matter
    Pages 205-206

About this book


 This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets.


Angiogenesis Inhibition Angiogenesis Stimulation Impact of angiogenesis modulation Nanotechnology and angiogenesis Neurohormonal regulation of angiogenesis

Editors and affiliations

  • Shaker A. Mousa
    • 1
  • Paul J. Davis
    • 2
  1. 1., Pharmaceutical Research InstituteAlbany College of Pharmacy and Health ScRensselaerUSA
  2. 2.and Health Sciences, Pharmaceutical Research InstituteAlbany College of PharmacyRensselaerUSA

Bibliographic information

Industry Sectors
Health & Hospitals
Consumer Packaged Goods